Search research articles
Contact Us
Filters
Showing results (171-180 of 241) with videos related to
Page
of 25
Sort By:
The American Journal of Pathology
|
November 1, 1990
Hodgkin's disease and CD30-positive anaplastic large cell lymphomas--a continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study
L Leoncini, M T Del Vecchio, R Kraft, et al.
Transplantation Proceedings
|
June 27, 2006
Posttransplant lymphoproliferative disorders in liver transplanted patients: a report of four cases
S Lorenzini, P Andreone, A Gramenzi, et al.
British Journal of Haematology
|
August 1, 1993
Lymphotoxin, tumour necrosis factor and interleukin-6 gene transcripts are present in Hodgkin and Reed-Sternberg cells of most Hodgkin's disease cases
H D Foss, H Herbst, E Oelmann, et al.
Cleveland Clinic Journal of Medicine
|
June 28, 2002
HCV and cryoglobulinemic vasculitis
C Ferri, A L Zignego, D Giuggioli, et al.
The American Journal of Pathology
|
August 1, 1995
A specific monoclonal antibody (PG-B6) detects expression of the BCL-6 protein in germinal center B cells
L Flenghi, B H Ye, M Fizzotti, et al.
Clinical and Experimental Immunology
|
October 1, 1987
Normal and neoplastic plasma cell membrane phenotype: studies with new monoclonal antibodies
P L Tazzari, M Gobbi, A Dinota, et al.
Haematologica
|
July 1, 1987
Clinicopathological study on non-Hodgkin's lymphomas
P Mazza, F Gherlinzoni, G Kemna, et al.
Haematologica
|
December 20, 1999
An Epstein-Barr virus-infected lymphoblastoid cell line (D430B) that grows in SCID-mice with the morphologic features of a CD30+ anaplastic large cell lymphoma, and is sensitive to anti-CD30 immunotoxins
P L Tazzari, D de Totero, A Bolognesi, et al.
Leukemia & Lymphoma
|
February 1, 1995
MACOP-B vs F-MACHOP regimen in the treatment of high-grade non-Hodgkin's lymphomas
P Mazza, P L Zinzani, M Martelli, et al.
Blood
|
April 1, 1995
Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product: immunocytochemical evidence for high expression of PML proteins on activated macrophages, endothelial cells, and epithelia
L Flenghi, M Fagioli, L Tomassoni, et al.
Page
of 25
Search research articles
Search
Showing results (171-180 of 241) with videos related to
Sort By:
Page
of 25
The American Journal of Pathology
|
November 1, 1990
Hodgkin's disease and CD30-positive anaplastic large cell lymphomas--a continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study
L Leoncini, M T Del Vecchio, R Kraft, et al.
Transplantation Proceedings
|
June 27, 2006
Posttransplant lymphoproliferative disorders in liver transplanted patients: a report of four cases
S Lorenzini, P Andreone, A Gramenzi, et al.
British Journal of Haematology
|
August 1, 1993
Lymphotoxin, tumour necrosis factor and interleukin-6 gene transcripts are present in Hodgkin and Reed-Sternberg cells of most Hodgkin's disease cases
H D Foss, H Herbst, E Oelmann, et al.
Cleveland Clinic Journal of Medicine
|
June 28, 2002
HCV and cryoglobulinemic vasculitis
C Ferri, A L Zignego, D Giuggioli, et al.
The American Journal of Pathology
|
August 1, 1995
A specific monoclonal antibody (PG-B6) detects expression of the BCL-6 protein in germinal center B cells
L Flenghi, B H Ye, M Fizzotti, et al.
Clinical and Experimental Immunology
|
October 1, 1987
Normal and neoplastic plasma cell membrane phenotype: studies with new monoclonal antibodies
P L Tazzari, M Gobbi, A Dinota, et al.
Haematologica
|
July 1, 1987
Clinicopathological study on non-Hodgkin's lymphomas
P Mazza, F Gherlinzoni, G Kemna, et al.
Haematologica
|
December 20, 1999
An Epstein-Barr virus-infected lymphoblastoid cell line (D430B) that grows in SCID-mice with the morphologic features of a CD30+ anaplastic large cell lymphoma, and is sensitive to anti-CD30 immunotoxins
P L Tazzari, D de Totero, A Bolognesi, et al.
Leukemia & Lymphoma
|
February 1, 1995
MACOP-B vs F-MACHOP regimen in the treatment of high-grade non-Hodgkin's lymphomas
P Mazza, P L Zinzani, M Martelli, et al.
Blood
|
April 1, 1995
Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product: immunocytochemical evidence for high expression of PML proteins on activated macrophages, endothelial cells, and epithelia
L Flenghi, M Fagioli, L Tomassoni, et al.
Page
of 25